Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease

FASEB Journal

Volumn 25, Issue 4, 2011, Pages 1345-1352

  Westerlund, Marie ^a   Behbahani, Homira ^a   Gellhaar, Sandra ^a   Forsell, Charlotte ^a   Belin, Andrea Carmine ^a   Anvret, Anna ^a   Zettergren, Anna ^b   Nissbrandt, Hans ^b   Lind, Charlotta ^c   Sydow, Olof ^c   Graff, Caroline ^a,c   Olson, Lars ^a   Ankarcrona, Maria ^a   Galter, Dagmar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

In situ hybridization; Postmortem tissue; Protease assay; PRSS25; Western blot

Indexed keywords

MESSENGER RNA; SERINE PROTEINASE OMI;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; GENE FREQUENCY; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWEDEN; WESTERN BLOTTING;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CEREBRAL CORTEX; GENE FREQUENCY; HIPPOCAMPUS; HUMANS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MUTATION, MISSENSE; PARKINSON DISEASE; SERINE ENDOPEPTIDASES;

EID: 79954625572     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-163402     Document Type: Article

References (36)

1. Gray, C. W., Ward, R. V., Karran, E., Turconi, S., Rowles, A., Viglienghi, D., Southan, C., Barton, A., Fantom, K. G., West, A., Savopoulos, J., Hassan, N. J., Clinkenbeard, H., Hanning, C., Amegadzie, B., Davis, J. B., Dingwall, C., Livi, G. P., and Creasy, C. L. (2000) Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur. J. Biochem. 267, 5699-5710
2. Gupta, S., Singh, R., Datta, P., Zhang, Z., Orr, C., Lu, Z., Dubois, G., Zervos, A. S., Meisler, M. H., Srinivasula, S. M., Fernandes-Alnemri, T., and Alnemri, E. S. (2004) The C-terminal tail of presenilin regulates Omi/HtrA2 protease activity. J. Biol. Chem. 279, 45844-45854 (Pubitemid 39491577)
3. Behbahani, H., Pavlov, P. F., Wiehager, B., Nishimura, T., Winblad, B., and Ankarcrona, M. (2010) Association of Omi/HtrA2 with gamma-secretase in mitochondria. Neurochem. Int. 57, 668-675
4. Park, H. J., Seong, Y. M., Choi, J. Y., Kang, S., and Rhim, H. (2004) Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neurosci. Lett. 357, 63-67 (Pubitemid 38186671)
5. Kooistra, J., Milojevic, J., Melacini, G., and Ortega, J. (2009) A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor. J. Alzheimers Dis. 17, 281-294
6. Huttunen, H. J., Guenette, S. Y., Peach, C., Greco, C., Xia, W., Kim, D. Y., Barren, C., Tanzi, R. E., and Kovacs, D. M. (2007) HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation. J. Biol. Chem. 282, 28285-28295 (Pubitemid 47529538)
7. Liu, M. L., Liu, M. J., Shen, Y. F., Ryu, H., Kim, H. J., Klupsch, K., Downward, J., and Hong, S. T. (2009) Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-beta. J. Cell Sci. 122, 1917-1926
8. Jones, J. M., Albin, R. L., Feldman, E. L., Simin, K., Schuster, T. G., Dunnick, W. A., Collins, J. T., Chrisp, C. E., Taylor, B. A., and Meisler, M. H. (1993) mnd2: a new mouse model of inherited motor neuron disease. Genomics 16, 669-677 (Pubitemid 23183487)
9. Jones, J. M., Datta, P., Srinivasula, S. M., Ji, W., Gupta, S., Zhang, Z., Davies, E., Hajnoczky, G., Saunders, T. L., Van Keuren, M. L., Fernandes-Alnemri, T., Meisler, M. H., and Alnemri, E. S. (2003) Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425, 721-727 (Pubitemid 37314315)
10. Alnemri, E. S. (2007) HtrA2 and Parkinson's disease: think PINK? Nat. Cell Biol. 9, 1227-1229 (Pubitemid 350042353)
11. Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R. J., McDonald, N., Wood, N. W., Martins, L. M., and Downward, J. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat. Cell Biol. 9, 1243-1252 (Pubitemid 350042356)
12. Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Muller, T., Bornemann, A., Wolburg, H., Downward, J., Riess, O., Schulz, J. B., and Kruger, R. (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099-2111 (Pubitemid 41418010)
13. Vande Walle, L., Lamkanfi, M., and Vandenabeele, P. (2008) The mitochondrial serine protease HtrA2/Omi: an overview. Cell Death Differ. 15, 453-460 (Pubitemid 351267296)
14. Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., and Takahashi, R. (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8, 613-621 (Pubitemid 32946938)
15. Hegde, R., Srinivasula, S. M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A. S., Fernandes-Alnemri, T., and Alnemri, E. S. (2002) Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277, 432-438 (Pubitemid 34952076)
16. Martins, L. M., Iaccarino, I., Tenev, T., Gschmeissner, S., Totty, N. F., Lemoine, N. R., Savopoulos, J., Gray, C. W., Creasy, C. L., Dingwall, C., and Downward, J. (2002) The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 277, 439-444 (Pubitemid 34952077)
17. Verhagen, A. M., Silke, J., Ekert, P. G., Pakusch, M., Kaufmann, H., Connolly, L. M., Day, C. L., Tikoo, A., Burke, R., Wrobel, C., Moritz, R. L., Simpson, R. J., and Vaux, D. L. (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem. 277, 445-454 (Pubitemid 34952078)
18. Vande Walle, L., Wirawan, E., Lamkanfi, M., Festjens, N., Verspurten, J., Saelens, X., Vanden Berghe, T., and Vandenabeele, P. (2010) The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal. Cell Res. 20, 421-433
19. Kieper, N., Holmstrom, K. M., Ciceri, D., Fiesel, F. C., Wolburg, H., Ziviani, E., Whitworth, A. J., Martins, L. M., Kahle, P. J., and Kruger, R. (2010) Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1. Exp. Cell Res. 316, 1213-1224
20. Dagda, R. K., and Chu, C. T. (2009) Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. J. Bioenerg. Biomembr. 41, 473-479
21. Li, B., Hu, Q., Wang, H., Man, N., Ren, H., Wen, L., Nukina, N., Fei, E., and Wang, G. (2010) Omi/HtrA2 is a positive regulator of autophagy that facilitates the degradation of mutant proteins involved in neurodegenerative diseases. Cell Death Differ. 17, 1773-1784
22. Kawamoto, Y., Ito, H., Kobayashi, Y., Suzuki, Y., and Takahashi, R. (2010) Localization of HtrA2/Omi immunoreactivity in brains affected by Alzheimer's disease. Neuroreport 21, 1121-1125
23. Martins, L. M., Turk, B. E., Cowling, V., Borg, A., Jarrell, E. T., Cantley, L. C., and Downward, J. (2003) Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi. J. Biol. Chem. 278, 49417-49427
24. Galter, D., Buervenich, S., Carmine, A., Anvret, M., and Olson, L. (2003) ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia. Neurobiol. Dis. 14, 637-647 (Pubitemid 37547970)
25. Galter, D., Westerlund, M., Belin, A. C., and Olson, L. (2007) DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents. Physiol. Behav. 92, 46-53 (Pubitemid 47374231)
26. Belin, A. C., Bjork, B. F., Westerlund, M., Galter, D., Sydow, O., Lind, C., Pernold, K., Rosvall, L., Hakansson, A., Winblad, B., Nissbrandt, H., Graff, C., and Olson, L. (2007) Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease. Neurosci. Lett. 420, 257-262 (Pubitemid 46856016)
27. Ronaghi, M., Uhlen, M., and Nyren, P. (1998) A sequencing method based on real-time pyrophosphate. Science 281, 363, 365
28. Liu, M. L., Liu, M. J., Kim, J. M., Kim, H. J., Kim, J. H., and Hong, S. T. (2005) HtrA2 interacts with A beta peptide but does not directly alter its production or degradation. Mol. Cells 20, 83-89
29. Seong, Y. M., Choi, J. Y., Park, H. J., Kim, K. J., Ahn, S. G., Seong, G. H., Kim, I. K., Kang, S., and Rhim, H. (2004) Autocatalytic processing of HtrA2/Omi is essential for induction of caspasedependent cell death through antagonizing XIAP. J. Biol. Chem. 279, 37588-37596 (Pubitemid 39195472)
30. Miners, J. S., Baig, S., Tayler, H., Kehoe, P. G., and Love, S. (2009) Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J. Neuropathol. Exp. Neurol. 68, 902-914
31. Miners, J. S., Van Helmond, Z., Chalmers, K., Wilcock, G., Love, S., and Kehoe, P. G. (2006) Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 65, 1012-1021 (Pubitemid 44521802)
32. Carpentier, M., Robitaille, Y., DesGroseillers, L., Boileau, G., and Marcinkiewicz, M. (2002) Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 61, 849-856
33. Ross, O. A., Soto, A. I., Vilarino-Guell, C., Heckman, M. G., Diehl, N. N., Hulihan, M. M., Aasly, J. O., Sando, S., Gibson, J. M., Lynch, T., Krygowska-Wajs, A., Opala, G., Barcikowska, M., Czyzewski, K., Uitti, R. J., Wszolek, Z. K., and Farrer, M. J. (2008) Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism Relat. Disord. 14, 539-543
34. Simon-Sanchez, J., and Singleton, A. B. (2008) Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Hum. Mol. Genet. 17, 1988-1993 (Pubitemid 351865847)
35. Kruger, R., Sharma, M., Riess, O., Gasser, T., Van Broeckhoven, C., Theuns, J., Aasly, J., Annesi, G., Bentivoglio, A. R., Brice, A., Djarmati, A., Elbaz, A., Farrer, M., Ferrarese, C., Gibson, J. M., Hadjigeorgiou, G. M., Hattori, N., Ioannidis, J. P., Jasinska-Myga, B., Klein, C., Lambert, J. C., Lesage, S., Lin, J. J., Lynch, T., Mellick, G. D., de Nigris, F., Opala, G., Prigione, A., Quattrone, A., Ross, O. A., Satake, W., Silburn, P. A., Tan, E. K., Toda, T., Tomiyama, H., Wirdefeldt, K., Wszolek, Z., Xiromerisiou, G., and Maraganore, D. M. (2009) A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. [E-pub ahead of print] Neurobiol Aging doi: 10.1016/j.neurobiolaging.2009.11.021
36. Bogaerts, V., Nuytemans, K., Reumers, J., Pals, P., Engelborghs, S., Pickut, B., Corsmit, E., Peeters, K., Schymkowitz, J., De Deyn, P. P., Cras, P., Rousseau, F., Theuns, J., and Van Broeckhoven, C. (2008) Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. Hum. Mutat. 29, 832-840 (Pubitemid 351794134)